CABALETTA BIO INC's ticker is CABA and the CUSIP is 12674W109. A total of 85 filers reported holding CABALETTA BIO INC in Q2 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $770,452 | +17.9% | 50,621 | 0.0% | 0.02% | +18.8% |
| Q2 2023 | $653,517 | -55.1% | 50,621 | -71.2% | 0.02% | -59.0% |
| Q1 2023 | $1,455,115 | -10.6% | 175,951 | 0.0% | 0.04% | -7.1% |
| Q4 2022 | $1,627,547 | +1007.2% | 175,951 | -22.1% | 0.04% | +950.0% |
| Q3 2022 | $147,000 | -45.6% | 225,951 | -11.2% | 0.00% | -33.3% |
| Q2 2022 | $270,000 | +8.9% | 254,552 | +108.1% | 0.01% | +20.0% |
| Q1 2022 | $248,000 | -36.2% | 122,330 | +249.5% | 0.01% | -28.6% |
| Q1 2021 | $389,000 | – | 35,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 2,106,000 | $32,053,320 | 21.20% |
| COMMODORE CAPITAL LP | 2,525,753 | $38,441,961 | 4.49% |
| Bain Capital Life Sciences Investors, LLC | 2,000,000 | $30,440,000 | 3.40% |
| VR Adviser, LLC | 1,973,253 | $30,032,911 | 3.16% |
| Cormorant Asset Management, LP | 2,879,424 | $43,824,833 | 2.56% |
| Velan Capital Investment Management LP | 150,000 | $2,283,000 | 1.84% |
| Redmile Group, LLC | 1,774,252 | $27,004,115 | 1.28% |
| TCG Crossover Management, LLC | 486,795 | $7,409,020 | 1.09% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,340,118 | $35,616,596 | 0.78% |
| Integral Health Asset Management, LLC | 330,000 | $5,022,600 | 0.70% |